Chemotherapy is recommended for patients with ERBB2-positive and HR-negative tumors, node-positive disease, and high Oncotype recurrence scores in HR-positive and ERBB2-negative breast cancer.3,6. The gene discussed is ERBB2; the disease is breast carcinoma.